Free Trial
NYSE:MD

Pediatrix Medical Group (MD) Stock Price, News & Analysis

Pediatrix Medical Group logo
$14.96 +0.21 (+1.42%)
(As of 11/22/2024 ET)

About Pediatrix Medical Group Stock (NYSE:MD)

Key Stats

Today's Range
$14.57
$15.28
50-Day Range
$10.48
$16.06
52-Week Range
$6.62
$16.41
Volume
588,137 shs
Average Volume
815,756 shs
Market Capitalization
$1.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.10
Consensus Rating
Hold

Company Overview

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Pediatrix Medical Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
57th Percentile Overall Score

MD MarketRank™: 

Pediatrix Medical Group scored higher than 57% of companies evaluated by MarketBeat, and ranked 489th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pediatrix Medical Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Pediatrix Medical Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Pediatrix Medical Group are expected to grow by 9.52% in the coming year, from $1.26 to $1.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pediatrix Medical Group is -4.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pediatrix Medical Group is -4.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Pediatrix Medical Group has a PEG Ratio of 2.10. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Pediatrix Medical Group has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pediatrix Medical Group's valuation and earnings.
  • Percentage of Shares Shorted

    4.65% of the float of Pediatrix Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pediatrix Medical Group has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Pediatrix Medical Group has recently decreased by 10.25%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pediatrix Medical Group does not currently pay a dividend.

  • Dividend Growth

    Pediatrix Medical Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.65% of the float of Pediatrix Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pediatrix Medical Group has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Pediatrix Medical Group has recently decreased by 10.25%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pediatrix Medical Group has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Pediatrix Medical Group this week, compared to 3 articles on an average week.
  • Search Interest

    5 people have searched for MD on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pediatrix Medical Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $751,277.00 in company stock.

  • Percentage Held by Insiders

    Only 2.00% of the stock of Pediatrix Medical Group is held by insiders.

  • Percentage Held by Institutions

    97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pediatrix Medical Group's insider trading history.
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

MD Stock News Headlines

Let’s be blunt
Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!
Pediatrix Medical Group (NYSE:MD) Cut to Hold at StockNews.com
Pediatrix Medical Group: The Business Is Turning
Jefferies Reaffirms Their Buy Rating on Pediatrix Medical Group (MD)
See More Headlines

MD Stock Analysis - Frequently Asked Questions

Pediatrix Medical Group's stock was trading at $9.30 at the beginning of 2024. Since then, MD stock has increased by 60.9% and is now trading at $14.96.
View the best growth stocks for 2024 here
.

Pediatrix Medical Group, Inc. (NYSE:MD) announced its earnings results on Friday, November, 1st. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.07. The business's quarterly revenue was up .9% compared to the same quarter last year.

Pediatrix Medical Group's top institutional shareholders include Rubric Capital Management LP (9.64%), State Street Corp (4.12%), Geode Capital Management LLC (2.26%) and Charles Schwab Investment Management Inc. (1.59%). Insiders that own company stock include C Marc Richards, James D Swift, Mark S Ordan, Mary Ann E Moore, Laura A Linynsky, Shirley A Weis and Roger Md Medel.
View institutional ownership trends
.

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pediatrix Medical Group investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
11/01/2024
Today
11/22/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/18/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Services
CUSIP
58502B10
Employees
5,170
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$16.10
High Stock Price Target
$18.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+7.6%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-60,410,000.00
Pretax Margin
-13.63%

Debt

Sales & Book Value

Annual Sales
$1.99 billion
Cash Flow
$1.61 per share
Book Value
$8.53 per share

Miscellaneous

Free Float
84,162,000
Market Cap
$1.28 billion
Optionable
Optionable
Beta
1.55

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:MD) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners